25 XP   0   0   10

Fusen Pharmaceutical Company Ltd
Buy, Hold or Sell?

Let's analyse Fusen Pharmaceutical Company Ltd together

PenkeI guess you are interested in Fusen Pharmaceutical Company Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Fusen Pharmaceutical Company Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Fusen Pharmaceutical Company Ltd

I send you an email if I find something interesting about Fusen Pharmaceutical Company Ltd.

Quick analysis of Fusen Pharmaceutical Company Ltd (30 sec.)










What can you expect buying and holding a share of Fusen Pharmaceutical Company Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
HK$0.81
Expected worth in 1 year
HK$0.63
How sure are you?
87.5%

+ What do you gain per year?

Total Gains per Share
HK$-0.14
Return On Investment
-15.8%

For what price can you sell your share?

Current Price per Share
HK$0.91
Expected price per share
HK$0.9359 - HK$1.15
How sure are you?
50%

1. Valuation of Fusen Pharmaceutical Company Ltd (5 min.)




Live pricePrice per Share (EOD)

HK$0.91

Intrinsic Value Per Share

HK$-0.48 - HK$1.95

Total Value Per Share

HK$0.33 - HK$2.76

2. Growth of Fusen Pharmaceutical Company Ltd (5 min.)




Is Fusen Pharmaceutical Company Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$78.3m$83.9m-$5.6m-7.2%

How much money is Fusen Pharmaceutical Company Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$4.4m$2.1m-$6.5m-148.1%
Net Profit Margin-7.0%4.3%--

How much money comes from the company's main activities?

3. Financial Health of Fusen Pharmaceutical Company Ltd (5 min.)




What can you expect buying and holding a share of Fusen Pharmaceutical Company Ltd? (5 min.)

Welcome investor! Fusen Pharmaceutical Company Ltd's management wants to use your money to grow the business. In return you get a share of Fusen Pharmaceutical Company Ltd.

What can you expect buying and holding a share of Fusen Pharmaceutical Company Ltd?

First you should know what it really means to hold a share of Fusen Pharmaceutical Company Ltd. And how you can make/lose money.

Speculation

The Price per Share of Fusen Pharmaceutical Company Ltd is HK$0.91. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Fusen Pharmaceutical Company Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Fusen Pharmaceutical Company Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$0.81. Based on the TTM, the Book Value Change Per Share is HK$-0.05 per quarter. Based on the YOY, the Book Value Change Per Share is HK$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Fusen Pharmaceutical Company Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps-0.01-0.6%-0.01-0.6%0.000.3%0.010.7%0.011.0%
Usd Book Value Change Per Share-0.01-0.6%-0.01-0.6%0.000.0%0.011.6%0.011.4%
Usd Dividend Per Share0.000.1%0.000.1%0.000.2%0.000.1%0.000.5%
Usd Total Gains Per Share0.00-0.5%0.00-0.5%0.000.2%0.021.7%0.021.9%
Usd Price Per Share0.18-0.18-0.16-0.37-0.23-
Price to Earnings Ratio-31.34--31.34-57.36-33.48-20.93-
Price-to-Total Gains Ratio-39.75--39.75-91.19-375.32-375.32-
Price to Book Ratio1.77-1.77-1.45-3.48-2.18-
Price-to-Total Gains Ratio-39.75--39.75-91.19-375.32-375.32-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.116298
Number of shares8598
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.01
Usd Total Gains Per Share0.000.02
Gains per Quarter (8598 shares)-39.53134.41
Gains per Year (8598 shares)-158.12537.65
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
140-198-16828510528
281-397-3265610191066
3121-595-4848415291604
4161-794-64211220382142
5202-992-80014125482680
6242-1191-95816930573218
7282-1389-111619735673756
8323-1588-127422540764294
9363-1786-143225345864832
10403-1984-159028150955370

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%7.01.00.087.5%7.01.00.087.5%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%5.03.00.062.5%5.03.00.062.5%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%7.01.00.087.5%7.01.00.087.5%

Fundamentals of Fusen Pharmaceutical Company Ltd

About Fusen Pharmaceutical Company Ltd

Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions, Ganweikang tablets, and Yixinkang tablets. It also researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold and fever, cardiovascular diseases, and anemia. In addition, the company offers business management and consulting services. Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.

Fundamental data was last updated by Penke on 2024-03-25 10:10:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Fusen Pharmaceutical Company Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Fusen Pharmaceutical Company Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Fusen Pharmaceutical Company Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -7.0% means that $-0.07 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Fusen Pharmaceutical Company Ltd:

  • The MRQ is -7.0%. The company is making a loss. -1
  • The TTM is -7.0%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-7.0%TTM-7.0%0.0%
TTM-7.0%YOY4.3%-11.4%
TTM-7.0%5Y9.4%-16.4%
5Y9.4%10Y12.7%-3.4%
1.1.2. Return on Assets

Shows how efficient Fusen Pharmaceutical Company Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Fusen Pharmaceutical Company Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.6% Return on Assets means that Fusen Pharmaceutical Company Ltd generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Fusen Pharmaceutical Company Ltd:

  • The MRQ is -2.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.6%TTM-2.6%0.0%
TTM-2.6%YOY1.3%-3.9%
TTM-2.6%5Y3.5%-6.1%
5Y3.5%10Y4.9%-1.4%
1.1.3. Return on Equity

Shows how efficient Fusen Pharmaceutical Company Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Fusen Pharmaceutical Company Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -5.6% Return on Equity means Fusen Pharmaceutical Company Ltd generated $-0.06 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Fusen Pharmaceutical Company Ltd:

  • The MRQ is -5.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.6%TTM-5.6%0.0%
TTM-5.6%YOY2.5%-8.2%
TTM-5.6%5Y6.4%-12.0%
5Y6.4%10Y23.5%-17.1%

1.2. Operating Efficiency of Fusen Pharmaceutical Company Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Fusen Pharmaceutical Company Ltd is operating .

  • Measures how much profit Fusen Pharmaceutical Company Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Fusen Pharmaceutical Company Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 9.2% means the company generated $0.09  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Fusen Pharmaceutical Company Ltd:

  • The MRQ is 9.2%. The company is operating less efficient.
  • The TTM is 9.2%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ9.2%TTM9.2%0.0%
TTM9.2%YOY17.1%-7.9%
TTM9.2%5Y16.4%-7.2%
5Y16.4%10Y19.9%-3.5%
1.2.2. Operating Ratio

Measures how efficient Fusen Pharmaceutical Company Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.46 means that the operating costs are $1.46 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Fusen Pharmaceutical Company Ltd:

  • The MRQ is 1.464. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.464. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.464TTM1.4640.000
TTM1.464YOY1.285+0.179
TTM1.4645Y1.129+0.335
5Y1.12910Y0.985+0.145

1.3. Liquidity of Fusen Pharmaceutical Company Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Fusen Pharmaceutical Company Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.85 means the company has $0.85 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Fusen Pharmaceutical Company Ltd:

  • The MRQ is 0.850. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.850. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.850TTM0.8500.000
TTM0.850YOY1.041-0.190
TTM0.8505Y1.304-0.454
5Y1.30410Y1.204+0.100
1.3.2. Quick Ratio

Measures if Fusen Pharmaceutical Company Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Fusen Pharmaceutical Company Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.10 means the company can pay off $0.10 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Fusen Pharmaceutical Company Ltd:

  • The MRQ is 0.102. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.102. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.102TTM0.1020.000
TTM0.102YOY0.284-0.181
TTM0.1025Y1.223-1.121
5Y1.22310Y1.087+0.136

1.4. Solvency of Fusen Pharmaceutical Company Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Fusen Pharmaceutical Company Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Fusen Pharmaceutical Company Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.55 means that Fusen Pharmaceutical Company Ltd assets are financed with 54.6% credit (debt) and the remaining percentage (100% - 54.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Fusen Pharmaceutical Company Ltd:

  • The MRQ is 0.546. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.546. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.546TTM0.5460.000
TTM0.546YOY0.470+0.076
TTM0.5465Y0.475+0.071
5Y0.47510Y0.616-0.141
1.4.2. Debt to Equity Ratio

Measures if Fusen Pharmaceutical Company Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Fusen Pharmaceutical Company Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 120.1% means that company has $1.20 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Fusen Pharmaceutical Company Ltd:

  • The MRQ is 1.201. The company is able to pay all its debts with equity. +1
  • The TTM is 1.201. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.201TTM1.2010.000
TTM1.201YOY0.885+0.316
TTM1.2015Y0.919+0.282
5Y0.91910Y2.934-2.015

2. Market Valuation of Fusen Pharmaceutical Company Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Fusen Pharmaceutical Company Ltd generates.

  • Above 15 is considered overpriced but always compare Fusen Pharmaceutical Company Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -31.34 means the investor is paying $-31.34 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Fusen Pharmaceutical Company Ltd:

  • The EOD is -19.945. Based on the earnings, the company is expensive. -2
  • The MRQ is -31.341. Based on the earnings, the company is expensive. -2
  • The TTM is -31.341. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-19.945MRQ-31.341+11.397
MRQ-31.341TTM-31.3410.000
TTM-31.341YOY57.358-88.699
TTM-31.3415Y33.483-64.824
5Y33.48310Y20.927+12.556
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Fusen Pharmaceutical Company Ltd:

  • The EOD is 7.967. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 12.520. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 12.520. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD7.967MRQ12.520-4.553
MRQ12.520TTM12.5200.000
TTM12.520YOY-15.308+27.828
TTM12.5205Y-6.855+19.375
5Y-6.85510Y-4.284-2.571
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Fusen Pharmaceutical Company Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Fusen Pharmaceutical Company Ltd:

  • The EOD is 1.126. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.770. Based on the equity, the company is underpriced. +1
  • The TTM is 1.770. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.126MRQ1.770-0.643
MRQ1.770TTM1.7700.000
TTM1.770YOY1.453+0.316
TTM1.7705Y3.480-1.711
5Y3.48010Y2.175+1.305
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Fusen Pharmaceutical Company Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.045-0.0450%0.003-1707%0.116-139%0.101-145%
Book Value Per Share--0.8080.8080%0.853-5%0.827-2%0.595+36%
Current Ratio--0.8500.8500%1.041-18%1.304-35%1.204-29%
Debt To Asset Ratio--0.5460.5460%0.470+16%0.475+15%0.616-11%
Debt To Equity Ratio--1.2011.2010%0.885+36%0.919+31%2.934-59%
Dividend Per Share--0.0090.0090%0.011-15%0.006+43%0.035-74%
Eps---0.046-0.0460%0.022-311%0.052-187%0.070-166%
Free Cash Flow Per Share--0.1140.1140%-0.081+171%-0.024+121%0.035+230%
Free Cash Flow To Equity Per Share--0.0460.0460%-0.054+218%-0.036+178%-0.094+305%
Gross Profit Margin--1.0001.0000%1.0000%0.096+946%0.043+2234%
Intrinsic Value_10Y_max--1.948--------
Intrinsic Value_10Y_min---0.481--------
Intrinsic Value_1Y_max--0.083--------
Intrinsic Value_1Y_min---0.031--------
Intrinsic Value_3Y_max--0.335--------
Intrinsic Value_3Y_min---0.108--------
Intrinsic Value_5Y_max--0.690--------
Intrinsic Value_5Y_min---0.202--------
Market Cap673967840.000-61%1084567770.0001084567770.0000%954718160.000+14%2273808106.000-52%1421130066.250-24%
Net Profit Margin---0.070-0.0700%0.043-263%0.094-175%0.127-155%
Operating Margin--0.0920.0920%0.171-46%0.164-44%0.199-54%
Operating Ratio--1.4641.4640%1.285+14%1.129+30%0.985+49%
Pb Ratio1.126-57%1.7701.7700%1.453+22%3.480-49%2.175-19%
Pe Ratio-19.945+36%-31.341-31.3410%57.358-155%33.483-194%20.927-250%
Price Per Share0.910-57%1.4301.4300%1.240+15%2.896-51%1.810-21%
Price To Free Cash Flow Ratio7.967-57%12.52012.5200%-15.308+222%-6.855+155%-4.284+134%
Price To Total Gains Ratio-25.296+36%-39.751-39.7510%91.194-144%375.315-111%375.315-111%
Quick Ratio--0.1020.1020%0.284-64%1.223-92%1.087-91%
Return On Assets---0.026-0.0260%0.013-291%0.035-172%0.049-152%
Return On Equity---0.056-0.0560%0.025-323%0.064-188%0.235-124%
Total Gains Per Share---0.036-0.0360%0.014-365%0.122-129%0.136-127%
Usd Book Value--78327725.40078327725.4000%83957443.200-7%82449531.000-5%59575663.350+31%
Usd Book Value Change Per Share---0.006-0.0060%0.000-1707%0.015-139%0.013-145%
Usd Book Value Per Share--0.1030.1030%0.109-5%0.106-2%0.076+36%
Usd Dividend Per Share--0.0010.0010%0.001-15%0.001+43%0.004-74%
Usd Eps---0.006-0.0060%0.003-311%0.007-187%0.009-166%
Usd Free Cash Flow--11071058.40011071058.4000%-7970502.600+172%-2622251.520+124%3448539.225+221%
Usd Free Cash Flow Per Share--0.0150.0150%-0.010+171%-0.003+121%0.004+230%
Usd Free Cash Flow To Equity Per Share--0.0060.0060%-0.007+218%-0.005+178%-0.012+305%
Usd Market Cap86133089.952-61%138607761.006138607761.0060%122012980.848+14%290592675.947-52%181620422.467-24%
Usd Price Per Share0.116-57%0.1830.1830%0.158+15%0.370-51%0.231-21%
Usd Profit---4422519.000-4422519.0000%2127231.000-308%5303367.720-183%7097037.525-162%
Usd Revenue--62846544.60062846544.6000%49287859.200+28%57093985.440+10%55863392.850+13%
Usd Total Gains Per Share---0.005-0.0050%0.002-365%0.016-129%0.017-127%
 EOD+4 -4MRQTTM+0 -0YOY+10 -255Y+12 -2410Y+15 -21

3.2. Fundamental Score

Let's check the fundamental score of Fusen Pharmaceutical Company Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-19.945
Price to Book Ratio (EOD)Between0-11.126
Net Profit Margin (MRQ)Greater than0-0.070
Operating Margin (MRQ)Greater than00.092
Quick Ratio (MRQ)Greater than10.102
Current Ratio (MRQ)Greater than10.850
Debt to Asset Ratio (MRQ)Less than10.546
Debt to Equity Ratio (MRQ)Less than11.201
Return on Equity (MRQ)Greater than0.15-0.056
Return on Assets (MRQ)Greater than0.05-0.026
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Fusen Pharmaceutical Company Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.900
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Net Working Capital  432,766-219,177213,589-100,828112,761-92,80519,956-127,982-108,026
Income before Tax  123,814-60,00063,81414,59178,405-54,61423,791-54,784-30,993
Net Income  101,882-48,44853,43416,69770,131-53,48616,645-51,250-34,605
Net Income from Continuing Operations  101,909-49,65052,25910,40962,668-46,05516,613-51,267-34,654
Net Income Applicable to Common Shares  101,882-48,44853,43416,69770,131-53,48616,645-51,250-34,605



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in HKD. All numbers in thousands.

Summary
Total Assets1,350,268
Total Liabilities737,375
Total Stockholder Equity614,167
 As reported
Total Liabilities 737,375
Total Stockholder Equity+ 614,167
Total Assets = 1,350,268

Assets

Total Assets1,350,268
Total Current Assets614,056
Long-term Assets736,212
Total Current Assets
Cash And Cash Equivalents 128,106
Short-term Investments 4,595
Net Receivables 69,387
Inventory 123,488
Other Current Assets 51,193
Total Current Assets  (as reported)614,056
Total Current Assets  (calculated)376,769
+/- 237,287
Long-term Assets
Property Plant Equipment 314,370
Intangible Assets 215,858
Other Assets 27,675
Long-term Assets  (as reported)736,212
Long-term Assets  (calculated)557,903
+/- 178,309

Liabilities & Shareholders' Equity

Total Current Liabilities722,082
Long-term Liabilities15,293
Total Stockholder Equity614,167
Total Current Liabilities
Short Long Term Debt 225,842
Accounts payable 163,613
Other Current Liabilities 74,697
Total Current Liabilities  (as reported)722,082
Total Current Liabilities  (calculated)464,152
+/- 257,930
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt2,539
Long-term Liabilities  (as reported)15,293
Long-term Liabilities  (calculated)2,539
+/- 12,754
Total Stockholder Equity
Common Stock6,383
Retained Earnings 274,813
Total Stockholder Equity (as reported)614,167
Total Stockholder Equity (calculated)281,196
+/- 332,971
Other
Capital Stock6,383
Common Stock Shares Outstanding 758,439
Net Debt 97,736
Net Invested Capital 840,009
Net Tangible Assets 613,684
Net Working Capital -108,026
Property Plant and Equipment Gross 439,483



Balance Sheet

Currency in HKD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
1,361,477
1,151,088
951,220
1,163,262
1,176,229
1,241,347
1,239,336
1,350,268
1,350,2681,239,3361,241,3471,176,2291,163,262951,2201,151,0881,361,477
   > Total Current Assets 
1,156,165
944,910
752,749
883,765
674,395
660,367
509,222
614,056
614,056509,222660,367674,395883,765752,749944,9101,156,165
       Cash And Cash Equivalents 
32,569
244,390
474,621
561,108
331,044
297,038
81,063
128,106
128,10681,063297,038331,044561,108474,621244,39032,569
       Short-term Investments 
0
300,000
474,621
561,108
331,044
15,489
642
4,595
4,59564215,489331,044561,108474,621300,0000
       Net Receivables 
208,800
297,755
145,192
149,884
200,516
240,337
56,436
69,387
69,38756,436240,337200,516149,884145,192297,755208,800
       Inventory 
106,633
100,779
100,506
140,787
88,404
105,415
128,973
123,488
123,488128,973105,41588,404140,787100,506100,779106,633
       Other Current Assets 
20,202
301,986
32,430
26,472
48,099
58,495
37,350
51,193
51,19337,35058,49548,09926,47232,430301,98620,202
   > Long-term Assets 
0
206,178
198,471
279,497
501,834
580,980
730,114
736,212
736,212730,114580,980501,834279,497198,471206,1780
       Property Plant Equipment 
169,495
171,658
164,789
154,445
124,676
238,002
285,460
314,370
314,370285,460238,002124,676154,445164,789171,658169,495
       Goodwill 
0
0
0
0
7,054
0
0
0
0007,0540000
       Intangible Assets 
1,883
1,683
1,483
117,908
270,646
883
683
215,858
215,858683883270,646117,9081,4831,6831,883
       Long-term Assets Other 
0
206,178
198,471
2,304
2,126
2,099
2,099
6,099
6,0992,0992,0992,1262,304198,471206,1780
> Total Liabilities 
1,167,282
1,024,479
768,443
547,163
494,689
583,098
582,392
737,375
737,375582,392583,098494,689547,163768,4431,024,4791,167,282
   > Total Current Liabilities 
1,016,807
994,628
731,978
450,999
460,806
547,606
489,266
722,082
722,082489,266547,606460,806450,999731,978994,6281,016,807
       Short-term Debt 
636,662
571,492
360,000
100,000
190,000
178,500
140,915
0
0140,915178,500190,000100,000360,000571,492636,662
       Short Long Term Debt 
0
571,492
360,000
100,000
190,000
178,500
160,915
225,842
225,842160,915178,500190,000100,000360,000571,4920
       Accounts payable 
183,529
137,653
130,224
137,991
68,898
108,585
102,115
163,613
163,613102,115108,58568,898137,991130,224137,653183,529
       Other Current Liabilities 
196,616
182,645
76,389
69,052
56,787
95,788
80,647
74,697
74,69780,64795,78856,78769,05276,389182,645196,616
   > Long-term Liabilities 
0
29,851
36,465
96,164
33,883
35,492
93,126
15,293
15,29393,12635,49233,88396,16436,46529,8510
       Long term Debt Total 
149,600
29,186
31,600
90,000
20,000
20,000
77,940
0
077,94020,00020,00090,00031,60029,186149,600
       Capital Lease Obligations 
0
0
0
0
0
0
3,773
2,539
2,5393,773000000
> Total Stockholder Equity
189,583
121,065
180,565
613,935
673,445
659,442
658,169
614,167
614,167658,169659,442673,445613,935180,565121,065189,583
   Common Stock
71,445
71,633
1,274
6,732
6,732
6,513
6,479
6,383
6,3836,4796,5136,7326,7321,27471,63371,445
   Retained Earnings 
112,661
44,049
122,647
223,279
276,713
346,844
363,489
274,813
274,813363,489346,844276,713223,279122,64744,049112,661
   Capital Surplus 
0
0
69,586
384,263
375,943
274,784
259,458
0
0259,458274,784375,943384,26369,58600
   Treasury Stock00-3000000
   Other Stockholders Equity 
5,477
5,383
-12,942
-339
14,057
31,331
28,786
0
028,78631,33114,057-339-12,9425,3835,477



Balance Sheet

Currency in HKD. All numbers in thousands.




Cash Flow

Currency in HKD. All numbers in thousands.




Income Statement

Currency in HKD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue491,757
Cost of Revenue-266,736
Gross Profit225,021225,021
 
Operating Income (+$)
Gross Profit225,021
Operating Expense-453,150
Operating Income5,751-228,129
 
Operating Expense (+$)
Research Development-
Selling General Administrative188,642
Selling And Marketing Expenses-
Operating Expense453,150188,642
 
Net Interest Income (+$)
Interest Income36,744
Interest Expense-5,325
Other Finance Cost-41,829
Net Interest Income-10,410
 
Pretax Income (+$)
Operating Income5,751
Net Interest Income-10,410
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-30,9935,751
EBIT - interestExpense = 40,087
-30,944
-29,280
Interest Expense5,325
Earnings Before Interest and Taxes (EBIT)45,412-25,668
Earnings Before Interest and Taxes (EBITDA)15,550
 
After tax Income (+$)
Income Before Tax-30,993
Tax Provision-3,661
Net Income From Continuing Ops-34,654-34,654
Net Income-34,605
Net Income Applicable To Common Shares-34,605
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-10,410
 

Technical Analysis of Fusen Pharmaceutical Company Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Fusen Pharmaceutical Company Ltd. The general trend of Fusen Pharmaceutical Company Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Fusen Pharmaceutical Company Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Fusen Pharmaceutical Company Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.97 < 1 < 1.15.

The bearish price targets are: 0.9458 > 0.9458 > 0.9359.

Tweet this
Fusen Pharmaceutical Company Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Fusen Pharmaceutical Company Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Fusen Pharmaceutical Company Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Fusen Pharmaceutical Company Ltd.

Fusen Pharmaceutical Company Ltd Daily Moving Average Convergence/Divergence (MACD) ChartFusen Pharmaceutical Company Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Fusen Pharmaceutical Company Ltd. The current adx is .

Fusen Pharmaceutical Company Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Fusen Pharmaceutical Company Ltd.

Fusen Pharmaceutical Company Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Fusen Pharmaceutical Company Ltd.

Fusen Pharmaceutical Company Ltd Daily Relative Strength Index (RSI) ChartFusen Pharmaceutical Company Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Fusen Pharmaceutical Company Ltd.

Fusen Pharmaceutical Company Ltd Daily Stochastic Oscillator ChartFusen Pharmaceutical Company Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Fusen Pharmaceutical Company Ltd.

Fusen Pharmaceutical Company Ltd Daily Commodity Channel Index (CCI) ChartFusen Pharmaceutical Company Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Fusen Pharmaceutical Company Ltd.

Fusen Pharmaceutical Company Ltd Daily Chande Momentum Oscillator (CMO) ChartFusen Pharmaceutical Company Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Fusen Pharmaceutical Company Ltd.

Fusen Pharmaceutical Company Ltd Daily Williams %R ChartFusen Pharmaceutical Company Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Fusen Pharmaceutical Company Ltd.

Fusen Pharmaceutical Company Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Fusen Pharmaceutical Company Ltd.

Fusen Pharmaceutical Company Ltd Daily Average True Range (ATR) ChartFusen Pharmaceutical Company Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Fusen Pharmaceutical Company Ltd.

Fusen Pharmaceutical Company Ltd Daily On-Balance Volume (OBV) ChartFusen Pharmaceutical Company Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Fusen Pharmaceutical Company Ltd.

Fusen Pharmaceutical Company Ltd Daily Money Flow Index (MFI) ChartFusen Pharmaceutical Company Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Fusen Pharmaceutical Company Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-16RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Fusen Pharmaceutical Company Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Fusen Pharmaceutical Company Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.900
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Fusen Pharmaceutical Company Ltd with someone you think should read this too:
  • Are you bullish or bearish on Fusen Pharmaceutical Company Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Fusen Pharmaceutical Company Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Fusen Pharmaceutical Company Ltd

I send you an email if I find something interesting about Fusen Pharmaceutical Company Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Fusen Pharmaceutical Company Ltd.

Receive notifications about Fusen Pharmaceutical Company Ltd in your mailbox!